[Nephroprotection diabetes mellitus type 2: lessons from the ADVANCE trial].
S V Nedogoda
Index: Kardiologiia 51(12) , 57-9, (2011)
Full Text: HTML
Abstract
Based on the results of the ADVANCE study, the article considers the issues of medication nephroprotection in patients with type 2 diabetes mellitus, including patients with uncontrolled arterial hypertension. Potentials for use of fixed combination of perindopril + indapmide, which provides therapeutic effect at all stages of renal continuum, are discussed. It is established that improved control of blood pressure by combination of perindopril + indapmide leads to a significant decrease in mortality in DM 2 patients.
Related Compounds
Related Articles:
2014-10-15
[Eur. J. Pharm. Sci. 63 , 14-21, (2014)]
2013-03-01
[Saudi J. Kidney Dis. Transpl. 24(2) , 281-5, (2013)]
2014-10-01
[Forensic Sci. Int. 243 , 35-43, (2014)]
2015-01-01
[Anal. Chim. Acta 853 , 637-46, (2014)]
2015-01-01
[Anal. Chim. Acta 853 , 647-59, (2014)]